Home > Insider Trading > Exact Sciences Corp

Exact Sciences Corp (EXAS)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
31 - 40
Next >>

Exact Sciences Corporation (NASDAQ:EXAS) Q2 2023 Earnings Call Transcript

Operator: Good day and welcome to the Exact Sciences Second Quarter 2023 Earnings Call. Today's call is being recorded. All lines have been placed on mute to prevent any background noise.

Keep Reading →

August 2nd, 2023 - News Transcripts

Does Exact Sciences Corporation (EXAS) Have a Long Runway for Growth?

Baron Funds, an investment management company, released its “Baron Health Care Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here.

Keep Reading →

July 25th, 2023 - Hedge Fund Investor Letters News

5 Best Booming Stocks to Buy Now

DraftKings Inc. (NASDAQ:DKNG) operates a digital sports entertainment and gaming company.

Keep Reading →

June 9th, 2023 - Hedge Funds News

Should You Invest in Exact Sciences Corporation (EXAS) Now?

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.

Keep Reading →

May 18th, 2023 - Hedge Fund Investor Letters News

Exact Sciences Corporation (NASDAQ:EXAS) Q1 2023 Earnings Call Transcript

Operator: Thank you for standing by. My name is Jordan, and I'll be your conference operator today.

Keep Reading →

May 10th, 2023 - News Transcripts

5 Gene Editing Stocks With the Best Long-Term Potential

In this article, we will take a look at the 5 gene editing stocks with the best long-term potential.

Keep Reading →

April 26th, 2023 - Hedge Funds News

Cathie Wood's Stock Portfolio: Top 5 Stock Picks For 2023

On March 15, UiPath Inc. (NYSE:PATH) reported earnings for the fourth quarter of fiscal 2023.

Keep Reading →

April 5th, 2023 - Hedge Funds News

5 Most Promising Gene Editing Stocks According to Analysts

In this article, we will take a look at the 5 most promising gene editing stocks according to analysts.

Keep Reading →

March 29th, 2023 - Hedge Funds News

Exact Sciences Corporation (NASDAQ:EXAS) Q4 2022 Earnings Call Transcript

Operator: Good morning. My name is Rob and I will be your conference operator today. At this time, I'd like to welcome everyone to the Exact Sciences Fourth Quarter 2022 Earnings Conference Call.

Keep Reading →

February 23rd, 2023 - News Transcripts